Last reviewed · How we verify

NCT04222166

Registry of Amniotic Membrane: Evaluating Utilization and Outcomes in Various Applications

Completed Last updated 27 August 2021
What this trial tests

trial testing CAM in Orthopedic Disorder in 100 participants. Completed in 6 August 2021.

Timeline
16 December 2019
Primary endpoint
30 June 2021
6 August 2021

Quick facts

Lead sponsorMED Institute Inc.
StatusCompleted
Study typeOBSERVATIONAL
Enrollment100
Start date16 December 2019
Primary completion30 June 2021
Estimated completion6 August 2021
Sites2 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

MED Institute Inc.

Who can join

22 and older, any sex, with Orthopedic Disorder or Wound. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This registry will assess clinical outcomes following the use of Cryopreserved Amniotic Membrane (CAM) for the treatment of orthopedic and various other conditions. This registry will collect outcomes data via a registry of up to 100 patients who have received treatment with CAM in the post-market setting. Patients will be enrolled from up to five healthcare centers.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Orthopedic Disorder

Currently open trials in the same condition.

Other MED Institute Inc. trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04222166.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing